Interestingly, a higher reduction of the elevated levels of Aβ and Tau and improvement of learning and memory deficits were obtained with a NF made of chitosan NPs containing berberine, but not with the free drug, in scopolamine-treated AD rats [308]. Here, MAPT is linked to Alzheimer disease.